The study consists of an open-label AXS-14 treatment period followed by a randomised, double-blind treatment period.
LOS ANGELES (KABC) -- Fibromyalgia and chronic fatigue syndrome are two mysterious and debilitating conditions - and they're often confused with each other. Tiredness, pain, trouble concentrating and ...
Axsome Therapeutics AXSM announced the initiation of the phase III study called FORWARD with the dosing of the first patient, ...
When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. Fibromyalgia, a potentially ...
Pain—whether it's an achy joint or a sensitive limb—is agony enough by itself. But when you can't figure out what's causing the pain? Then it can feel more like torture. Unfortunately, that kind of ...
AXS-14 (esreboxetine) is a highly selective and potent norepinephrine reuptake inhibitor being developed for the management of fibromyalgia. Esreboxetine is the SS-enantiomer of racemic reboxetine.
Lady Gaga revealed this week on Twitter that she suffers from fibromyalgia, sparking curiosity among many of her fans about the chronic health condition, which is characterized by widespread pain and ...
San Antonio, TX - Pramipexole (Mirapex, Boehringer Ingelheim), a dopamine-3 agonist already used in the treatment of Parkinson's disease and restless-leg syndrome, has shown efficacy in fibromyalgia ...
Do you frequently feel worn out, exhausted, and achy muscles? If so, you may be one of the many corporate employees who unknowingly suffer from fibromyalgia. Chronic musculoskeletal pain, soreness, ...
Fibromyalgia is characterized by spontaneous and widespread pain and affects millions worldwide. There is evidence that the condition is more prevalent among women than men (by about seven to nine ...
A university-based study finds a high prevalence of fibromyalgia symptoms, strongly linked to anxiety, stress, and lifestyle ...
Fibromyalgia, a chronic disease that causes pain and swelling in more than a dozen points all over the body, affects as many as 5 million people. Because doctors are still unsure of the cause of ...